|Metformin 500mg tablets (Photo credit: Wikipedia)|
A common diabetes drug may slow another malignancy: ovarian cancer.
Ovarian cancer patients who were taking metformin at the time of their diagnosis survived longer than patients who weren't on the drug, a new study by Mayo Clinic researchers shows.
Metformin goes by the brand name Glucophage and is derived from French lilacs. It's typically prescribed to lower blood sugar levels in people with type 2 diabetes but has shown promise as a potential anticancer agent in recent prostate, colon, pancreas, brain, and breast cancer studies, as well as in lab experiments with ovarian cancer cells.